Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 397-402

  Egawa, Katsushi ^a   Yukawa, Tomo ^b   Arakawa, Shoichi ^c   Tanaka, Takeshi ^d   Tsuda, Fumio ^e   Okamoto, Hiroaki ^f   Miyakawa, Yuzo ^g   Mayumi, Makoto ^f  

^a National Suruga Leprosarium   (Japan)

^b Koyama Fukusei Byoin   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

^d JAPANESE RED CROSS SOCIETY   (Japan)

^e Toshiba General Hospital   (Japan)

^f JICHI MEDICAL UNIVERSITY   (Japan)

^g Mita Institute   (Japan)

Author keywords

Genotype; Hepatitis B virus; Hepatitis C; Hepatitis C virus; Leprosy; Mycobacterium leprae

Indexed keywords

HEPATITIS C ANTIBODY; INTERFERON; VIRUS RNA;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE CARRIER; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; JAPAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029989528     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80159-0     Document Type: Article

References (30)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
3. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-500.
4. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, Parmley R, Sexauer C, Comperts E, Buchanan G, Schwartz B, Adair S, Fields H. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993; 81: 412-8.
5. Chan TM, Lok AS, Cheng IK, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
6. Blumberg BS, Melanin L, Lechat M, Guinto RS. Association between lepromatous leprosy and Australia antigen. Lancet 1967; ii: 173-6.
7. Nuti M, Tarabini G, Palermo P, Tarabini GL, Thamer G. Leprosy and hepatitis B virus markers: incidence of HBsAg and HBeAg in Somalian patients. Int J Lepr Other Mycobact Dis 1979; 47: 580-4.
8. Yvonnet B, Vincelot P, Millan J, Lesage G, Denis F, Languillon J, M'Boup S, Coursaget P, Diop-Mar I, Chiron JP. Hepatitis B virus infection in lepromatous and tuberculoid patients from Senegal. Acta Leprol 1989; 7: 63-6.
9. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun 1992; 183: 334-42.
10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73:673-9.
11. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, lizuka H, Mishiro S. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993; 4: 2385-90.
12. Simmonds P, Smith DB, McOmish F, Yap PL, Kolberg J, Ureda MS, Holmes EC. Identification of genotypes of hepatitis C virus by sequence comparison in the core, E1 and NS-5 regions. J Gen Virol 1994; 75: 1053-61.
13. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215-22.
14. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/ 1a. Hepatology 1994; 20: 1131-6.
15. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Semin Liver Dis 1995; 15: 41-63.
16. Miyakawa Y, Okamoto H, Mayumi M. Classifying hepatitis C virus genotypes. Mol Med Today 1995; 1: 20-5.
17. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63: 107-11.
18. Nomura M, Imai M, Takahashi K, Kumakura T, Tachibana K, Aoyagi S, Usuda S, Nakamura T, Miyakawa Y, Mayumi M. Three-site sandwich radioimmunoassay with monoclonal antibodies for a sensitive determination of human alfa-fetoprotein. J Immunol Methods 1983; 58: 293-300.
19. Fukuda S, Suzuki T, Nagayama R, Tsuda F, Kojima M, Okamoto H, Tanaka T, Miyakawa Y, Mayumi M. Hepatitis C virus RNA in blood units with antibodies detectable by a second-generation passive hemagglutination assay, antibodies to synthetic core peptides or elevated transaminase levels. Transfus Sci 1994; 15: 83-92.
20. Frommel D, Tekle HR, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 1993; 49: 435-9.
21. Denis F, Aussel L, Ranger S, Martin P, Itoua-N'Gaporo A, Itoua-N'Gaporo A, Frommel D, Teckle-Haimanot RT, Sangare A, M'Boup S, Millan J, Al Qubati Y. Prevalence of antibodies to hepatitis C virus among patients with leprosy in several African countries and the Yemen. J Med Virol 1994; 43: 1-4.
22. Nishioka K. Hepatitis C virus infection in Japan. Gastroenterol Jpn 1991; 26: S152-5.
23. Wang JT, Wang TH, Sheu JC, Lin JT, Wang CY, Chen DS. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 1992; 103: 609-16.
24. Cohn ZA, Kaplan G. Hansen's disease, cell-mediated immunity, and recombinant lymphokines. J Infect Dis 1991; 163: 1195-200.
25. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
26. Hino K, Sainokami S, Shimoda K, lino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol 1994; 42: 299-305.
27. Kaplan G. Recent advances in cytokine therapy in leprosy. J Infect Dis 1993; 167: S18-22.
28. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67: 1953-8.
29. Kitamura H, Nagaki K, Inoshita K, Iida K, Inai S. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis. Clin Exp Immunol 1977; 27: 34-7.
30. Itoh K, Tanaka H, Shiga J, Hirakawa K, Akahane Y, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Hypocomplementemia associated with hepatitis C viremia in sera from volun-tary blood donors. Am J Gastroenterol 1994; 89: 2019-24.